ClinVar Miner

Submissions for variant NM_138694.4(PKHD1):c.778G>A (p.Glu260Lys)

dbSNP: rs1554222386
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000586728 SCV000699877 uncertain significance not provided 2017-01-23 criteria provided, single submitter clinical testing Variant summary: The PKHD1 c.778G>A (p.Glu260Lys) variant involves the alteration of a conserved nucleotide located at the end of exon 11. Exon 11 is involved in encoding immunoglobulin-like fold of the protein (via InterPro). 3/4 in silico tools predict a damaging outcome for this variant. In addition, 5/5 splice prediction tools predict a significant impact (i.e. abrogation or attenuation of utilization of consensus splice donor site) on normal splicing. Due to location of this variant, it may affect protein function by altering normal splicing. These predictions have yet to be confirmed by functional studies. This variant is absent in 121396 control chromosomes from ExAC. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories. Therefore, due to the absence of clinical and functional data, this variant is currently classified as a VUS until additional data becomes available.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.